Issues and prospects of image‐guided thermal ablation in the treatment of primary and metastatic lung tumors

The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image‐guided therm...

Full description

Saved in:
Bibliographic Details
Published inThoracic cancer Vol. 14; no. 1; pp. 110 - 115
Main Authors Wang, Meixiang, Wei, Zhigang, Ye, Xin
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.01.2023
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN1759-7706
1759-7714
1759-7714
DOI10.1111/1759-7714.14742

Cover

Abstract The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image‐guided thermal ablation (IGTA) comes with the characteristics such as more accurate localization, less trauma, more definite efficacy, higher safety, stronger repeatability, fewer complications, and lower cost in treating lung tumors. This paper investigates the existing problems of IGTA in the treatment of lung tumors and puts forward the orientation of studies.
AbstractList The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image‐guided thermal ablation (IGTA) comes with the characteristics such as more accurate localization, less trauma, more definite efficacy, higher safety, stronger repeatability, fewer complications, and lower cost in treating lung tumors. This paper investigates the existing problems of IGTA in the treatment of lung tumors and puts forward the orientation of studies.
Abstract The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image‐guided thermal ablation (IGTA) comes with the characteristics such as more accurate localization, less trauma, more definite efficacy, higher safety, stronger repeatability, fewer complications, and lower cost in treating lung tumors. This paper investigates the existing problems of IGTA in the treatment of lung tumors and puts forward the orientation of studies.
The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image-guided thermal ablation (IGTA) comes with the characteristics such as more accurate localization, less trauma, more definite efficacy, higher safety, stronger repeatability, fewer complications, and lower cost in treating lung tumors. This paper investigates the existing problems of IGTA in the treatment of lung tumors and puts forward the orientation of studies.The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors. New local treatment methods have emerged as solutions to the shortcomings of minimally invasive or local treatment methods. Image-guided thermal ablation (IGTA) comes with the characteristics such as more accurate localization, less trauma, more definite efficacy, higher safety, stronger repeatability, fewer complications, and lower cost in treating lung tumors. This paper investigates the existing problems of IGTA in the treatment of lung tumors and puts forward the orientation of studies.
Author Wei, Zhigang
Ye, Xin
Wang, Meixiang
AuthorAffiliation 2 Cheeloo College of Medicine Shandong University Jinan Shandong Province China
1 Department of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute Jinan Shandong Province China
AuthorAffiliation_xml – name: 1 Department of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute Jinan Shandong Province China
– name: 2 Cheeloo College of Medicine Shandong University Jinan Shandong Province China
Author_xml – sequence: 1
  givenname: Meixiang
  surname: Wang
  fullname: Wang, Meixiang
  organization: The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute
– sequence: 2
  givenname: Zhigang
  surname: Wei
  fullname: Wei, Zhigang
  email: weizhigang321321@163.com
  organization: Shandong University
– sequence: 3
  givenname: Xin
  orcidid: 0000-0002-4906-7746
  surname: Ye
  fullname: Ye, Xin
  email: yexintaian2020@163.com
  organization: The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36480492$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhSNUREvpmh2yxIbNtP5Jxs4GqRrxM1IlNmVtOfZ1mpFjD7YD6o5H4Bl5EpyZ6YhWQniT6OY7xyf33pfViQ8equo1wZeknCvCm3bBOakvSc1r-qw6O1ZOju94eVpdpLTB5TDRYtq8qE7Zsha4bulZ5dcpTZCQ8gZtY0hb0DmhYNEwqh5-__zVT4MBg_IdxFE5pDqn8hA8GvxcQzmCyiP4PGu2saji_c5shKxSLqxGbvI9ytMYYnpVPbfKJbg4PM-rrx8_3K4-L26-fFqvrm8WumGMLjoAzDixWgnKGmEMtkKzktlgozrWGEOBCctJ-b9WGyU0bi1vsWZYWd0BO6_We18T1EYecsmgBrkrhNhLFUs2B9J2jTIajKAdrzlrOk67hhFrSh-Fsax4vd97baduhIL6HJV7ZPr4ix_uZB--y1ZgXtd1MXh3MIjhW2l2luOQNDinPIQpScobRltCWlrQt0_QTZiiL60q1LKMULTLmXrzd6JjlIexFqDZA7qMNEWwUg95N7cScHCSYDlvkJx3RM77IncbVHRXT3QP1v9WHG76MTi4_x8ub1fXe90fLWzZDw
CitedBy_id crossref_primary_10_3389_fimmu_2023_1268331
crossref_primary_10_3390_curroncol31010009
crossref_primary_10_3390_jcm13237085
Cites_doi 10.1016/j.radonc.2020.10.028
10.21037/tlcr‐20‐1231
10.4103/jcrt.JCRT_850_20
10.21037/tcr‐20‐3020
10.1186/s13244-021-00997-5
10.1007/s00270-018-02153-x
10.1007/s00256-015-2195-4
10.4103/jcrt.JCRT_798_20
10.1111/1759-7714.14212
10.21037/tlcr‐20‐1075
10.21037/jtd‐2019‐cptn‐08
10.1016/j.yexcr.2021.112910
10.1080/02656736.2020.1756467
10.1016/j.ebiom.2019.05.036
10.1016/j.athoracsur.2018.10.049
10.1007/s00330-020-07634-7
10.1007/s00432-019-03043-6
10.1016/j.jtcvs.2021.01.143
10.21037/atm‐21‐6256
10.1016/j.jvir.2020.09.014
10.1016/j.jvir.2021.03.523
10.3390/cancers13040908
10.1007/s00330-020-07382-8
10.1007/s11912-021-01072-4
10.1148/radiol.2018180979.2018180979
10.1089/cbr.2020.3859
10.1007/s00330‐022‐08615‐8
10.1016/j.crad.2017.01.005
10.4103/jcrt.JCRT_990_19
10.1080/00365513.2019.1689428
10.1093/ejcts/ezac071
10.4103/jcrt.jcrt_1485_21
10.1038/s41416-021-01404-y
10.1007/s00330-020-07675-y
10.4103/jcrt.JCRT_1040_19
10.1016/j.jvir.2021.02.025
10.1016/S1470-2045(08)70155-413
10.21037/jtd.2019.12.12
10.1016/j.biochi.2021.03.007
10.1111/crj.13219
10.4103/jcrt.jcrt_531_21
10.1038/s41423-020-00630-3
10.3389/fonc.2020.571684
10.1002/cncr.29507
10.1111/ajco.13419
10.4103/jcrt.JCRT_377_20
10.4103/jcrt.JCRT_1399_20
10.1002/cncr.31196
10.1016/j.athoracsur.2021.04.061
10.1159/000468982
10.1186/s13244-019-0727-5
10.1007/s00330-019-06613-x
ContentType Journal Article
Copyright 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
– notice: 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1111/1759-7714.14742
DatabaseName Wiley Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central - New (Subscription)
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
CrossRef


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Wang et al
EISSN 1759-7714
EndPage 115
ExternalDocumentID oai_doaj_org_article_fb5adced82b74735b72b531fd7718df3
PMC9807444
36480492
10_1111_1759_7714_14742
TCA14742
Genre commentary
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Natural Science Foundation of Shandong Province
  funderid: ZR201911040313
– fundername: National Natural Science Foundation of China
  funderid: 81502610; 82072028
– fundername: ;
  grantid: 81502610; 82072028
– fundername: ;
  grantid: ZR201911040313
GroupedDBID ---
05W
0R~
1OC
24P
31~
4.4
50Y
53G
5VS
7X7
8-0
8-1
8FI
8FJ
AAHHS
AANHP
AAWTL
AAZKR
ABDBF
ABUWG
ACBWZ
ACCFJ
ACCMX
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADPDF
ADZMN
AEEZP
AENEX
AEQDE
AFBPY
AFKRA
AHMBA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
ASPBG
AVUZU
AVWKF
AZFZN
BCNDV
BDRZF
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
D-A
DIK
EBD
EBS
EJD
FEDTE
FYUFA
G-S
GODZA
GROUPED_DOAJ
HMCUK
HVGLF
HYE
HZ~
IAO
IHR
ITC
KQ8
MY.
MY~
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
RX1
SUPJJ
TEORI
UKHRP
WIN
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5332-bee0371fca82358dd0f8c3480d0dab35dd2e38f717709cda8c09f790c30afcbe3
IEDL.DBID 24P
ISSN 1759-7706
1759-7714
IngestDate Wed Aug 27 01:26:11 EDT 2025
Thu Aug 21 18:38:15 EDT 2025
Thu Sep 04 18:07:05 EDT 2025
Wed Aug 13 02:53:54 EDT 2025
Wed Feb 19 02:24:17 EST 2025
Thu Apr 24 23:03:11 EDT 2025
Tue Jul 01 00:59:11 EDT 2025
Wed Jan 22 16:19:50 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords non-small cell lung cancer
early-stage
image-guided thermal ablation
pulmonary metastases
issues and prospects
Language English
License Attribution
2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5332-bee0371fca82358dd0f8c3480d0dab35dd2e38f717709cda8c09f790c30afcbe3
Notes Funding information
National Natural Science Foundation of China, Grant/Award Numbers: 81502610, 82072028; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR201911040313
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding information National Natural Science Foundation of China, Grant/Award Numbers: 81502610, 82072028; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR201911040313
ORCID 0000-0002-4906-7746
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14742
PMID 36480492
PQID 2760008962
PQPubID 1006494
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_fb5adced82b74735b72b531fd7718df3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9807444
proquest_miscellaneous_2753291192
proquest_journals_2760008962
pubmed_primary_36480492
crossref_citationtrail_10_1111_1759_7714_14742
crossref_primary_10_1111_1759_7714_14742
wiley_primary_10_1111_1759_7714_14742_TCA14742
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2023
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: January 2023
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Singapore
– name: Tianjin
PublicationTitle Thoracic cancer
PublicationTitleAlternate Thorac Cancer
PublicationYear 2023
Publisher John Wiley & Sons Australia, Ltd
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: John Wiley & Sons, Inc
– name: Wiley
References 2021; 409
2021; 26
2021; 23
2019; 11
2021; 125
2019; 10
2018; 124
2018; 289
2019; 79
2019; 15
2015; 121
2008; 9
2020; 16
2020; 37
2020; 14
2020; 12
2021; 185
2020; 146
2020; 10
2019; 107
2022; 113
2017; 72
2021; 13
2021; 32
2021; 10
2022; 163
2021; 31
2021; 12
2019; 42
2020; 30
2019; 44
2022; 62
2021; 18
2021; 17
2017; 10
2015; 44
2022; 37
2021; 155
2022; 32
2022; 10
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
Shan Y (e_1_2_8_31_1) 2021; 26
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_10_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_52_1
e_1_2_8_50_1
References_xml – volume: 17
  start-page: 811
  issue: 3
  year: 2021
  end-page: 3
  article-title: Computed tomography‐guided percutaneous microwave ablation for pulmonary multiple ground‐glass opacities
  publication-title: J Cancer Res Ther
– volume: 23
  start-page: 81
  issue: 7
  year: 2021
  article-title: Is there a role for percutaneous ablation for early stage lung cancer? What is the evidence?
  publication-title: Curr Oncol Rep
– volume: 16
  start-page: 1718
  issue: 7
  year: 2020
  end-page: 21
  article-title: Immune abscopal effect of microwave ablation for lung metastases of endometrial carcinoma
  publication-title: J Cancer Res Ther
– volume: 9
  start-page: 621
  issue: 7
  year: 2008
  end-page: 8
  article-title: Response to radiofrequency ablation of pulmonary tumours: a prospective, intention‐to‐treat, multicentre clinical trial (the RAPTURE study)
  publication-title: Lancet Oncol
– volume: 12
  start-page: 7039
  issue: 11
  year: 2020
  end-page: 47
  article-title: Image guided thermal ablation in lung cancer treatment
  publication-title: J Thorac Dis
– volume: 10
  start-page: 1583
  issue: 3
  year: 2021
  end-page: 93
  article-title: Application of electromagnetic navigation bronchoscopy in the early diagnosis and treatment of lung cancer: a narrative review
  publication-title: Transl Cancer Res
– volume: 44
  start-page: 1485
  issue: 10
  year: 2015
  end-page: 90
  article-title: Computed tomography‐guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer
  publication-title: Skeletal Radiol
– volume: 10
  start-page: 383
  issue: 1
  year: 2017
  end-page: 7
  article-title: Microwave ablation and immune activation in the treatment of recurrent colorectal lung metastases: a case report
  publication-title: Case Rep Oncol
– volume: 12
  start-page: 3380
  issue: 24
  year: 2021
  end-page: 6
  article-title: CT‐guided microwave ablation in patients with lung metastases from breast cancer
  publication-title: Thorac Cancer
– volume: 16
  start-page: 1191
  issue: 5
  year: 2020
  end-page: 5
  article-title: Rechallenge of camrelizumab in non‐small‐cell lung cancer patients treated previously with camrelizumab and microwave ablation
  publication-title: J Cancer Res Ther
– volume: 16
  start-page: 957
  issue: 5
  year: 2020
  end-page: 9
  article-title: TATI modality: a new perspective on the treatment of advanced hepatocellular carcinoma
  publication-title: J Cancer Res Ther
– volume: 18
  start-page: 1106
  issue: 5
  year: 2021
  end-page: 21
  article-title: Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
  publication-title: Cell Mol Immunol
– volume: 155
  start-page: 254
  year: 2021
  end-page: 60
  article-title: The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early‐stage non‐small cell lung cancer
  publication-title: Radiother Oncol
– volume: 31
  start-page: 3530
  issue: 5
  year: 2021
  end-page: 41
  article-title: Percutaneous microwave ablation of bone tumors: a systematic review
  publication-title: Eur Radiol
– volume: 185
  start-page: 78
  year: 2021
  end-page: 86
  article-title: Role of pyroptosis in cancer cells and clinical applications
  publication-title: Biochimie
– volume: 10
  start-page: 104
  issue: 2
  year: 2022
  article-title: Comparison of stereotactic body radiotherapy and radiofrequency ablation for early‐stage non‐small cell lung cancer: a systematic review and meta‐analysis
  publication-title: Ann Transl Med
– volume: 124
  start-page: 667
  issue: 4
  year: 2018
  end-page: 78
  article-title: Surgery versus stereotactic body radiation therapy for stage I non‐small cell lung cancer: a comprehensive review
  publication-title: Cancer
– volume: 10
  year: 2020
  article-title: Thermal ablation versus wedge resection for stage I non‐small cell lung cancer based on the eighth edition of the TNM classification: a Population Study of the US SEER Database
  publication-title: Front Oncol
– volume: 32
  start-page: 861
  issue: 6
  year: 2021
  end-page: 8
  article-title: Computed tomography–guided microwave ablation combined with osteoplasty for the treatment of bone metastases: a multicenter clinical study
  publication-title: J Vasc Interv Radiol
– volume: 16
  start-page: 199
  issue: 2
  year: 2020
  end-page: 202
  article-title: Management of pulmonary multifocal ground‐glass nodules: how many options do we have?
  publication-title: J Cancer Res Ther
– volume: 32
  start-page: 187
  issue: 2
  year: 2021
  end-page: 95
  article-title: Thermal ablation, embolization, and selective internal radiation therapy combined with checkpoint inhibitor cancer immunotherapy: safety analysis
  publication-title: J Vasc Interv Radiol
– volume: 72
  start-page: 657
  year: 2017
  end-page: 64
  article-title: Lung ablation: best practice/results/response assessment/role alongside other ablative therapies
  publication-title: Clin Radiol
– volume: 44
  start-page: 112
  year: 2019
  end-page: 25
  article-title: High‐frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti‐tumor immunity
  publication-title: EBioMedicine
– volume: 10
  start-page: 1608
  issue: 4
  year: 2021
  end-page: 22
  article-title: Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance‐a novel technique and initial experience with 30 cases
  publication-title: Transl Lung Cancer Res
– volume: 10
  start-page: 2842
  issue: 6
  year: 2021
  end-page: 57
  article-title: Thermal ablation in non‐small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
  publication-title: Transl Lung Cancer Res
– volume: 107
  start-page: 1876
  issue: 6
  year: 2019
  end-page: 83
  article-title: Local recurrence after microwave ablation of lung malignancies: a systematic review
  publication-title: Ann Thorac Surg
– volume: 16
  start-page: 1007
  issue: 5
  year: 2020
  end-page: 13
  article-title: Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non‐small cell lung cancer
  publication-title: J Cancer Res Ther
– volume: 16
  start-page: 320
  issue: 6
  year: 2020
  end-page: 5
  article-title: Image‐guided percutaneous microwave ablation of early‐stage non‐small cell lung cancer
  publication-title: Asia Pac J Clin Oncol
– volume: 125
  start-page: 672
  issue: 5
  year: 2021
  end-page: 8
  article-title: Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non‐small‐cell lung cancer
  publication-title: Br J Cancer
– volume: 79
  start-page: 619
  issue: 8
  year: 2019
  end-page: 28
  article-title: Endothelial pyroptosis underlies systemic inflammatory response following radiofrequency ablation of hepatic hemangiomas
  publication-title: Scand J Clin Lab Invest
– volume: 11
  start-page: 5187
  issue: 12
  year: 2019
  end-page: 98
  article-title: A systematic review and meta‐analysis of stereotactic body radiation therapy for colorectal pulmonary metastases
  publication-title: J Thorac Dis
– volume: 409
  issue: 2
  year: 2021
  article-title: Incomplete radiofrequency ablation induced chemoresistance by up‐regulating heat shock protein 70 in hepatocellular carcinoma
  publication-title: Exp Cell Res
– volume: 62
  year: 2022
  article-title: Application of electromagnetic navigation bronchoscopy‐guided microwave ablation in multiple pulmonary nodules: a single‐centre study
  publication-title: Eur J Cardiothorac Surg
– volume: 163
  start-page: 495
  issue: 2
  year: 2022
  end-page: 502
  article-title: The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases
  publication-title: J Thorac Cardiovasc Surg
– volume: 12
  start-page: 57
  issue: 1
  year: 2021
  article-title: Image‐guided percutaneous ablation for the treatment of lung malignancies: current state of the art
  publication-title: Insights Imaging
– volume: 37
  start-page: 414
  issue: 1
  year: 2020
  end-page: 22
  article-title: A feasibility and safety study of computed tomography‐guided percutaneous microwave ablation: a novel therapy for multiple synchronous ground‐glass opacities of the lung
  publication-title: Int J Hyperthermia
– volume: 113
  start-page: 1307
  issue: 4
  year: 2022
  end-page: 15
  article-title: Electromagnetic navigation bronchoscopy‐guided microwave ablation combined with uniportal video‐assisted thoracoscopic surgery for multiple ground glass opacities
  publication-title: Ann Thorac Surg
– volume: 13
  issue: 4
  year: 2021
  article-title: Role of thermal ablation in colorectal cancer lung metastases
  publication-title: Cancers (Basel)
– volume: 31
  start-page: 5421
  issue: 7
  year: 2021
  end-page: 33
  article-title: Survival outcomes for surgical resection versus CT‐guided percutaneous ablation for stage I non‐small cell lung cancer (NSCLC): a systematic review and meta‐analysis
  publication-title: Eur Radiol
– volume: 14
  start-page: 864
  issue: 9
  year: 2020
  end-page: 70
  article-title: Comparative clinical study on microwave ablation combined with gemcitabine and cisplatin or combined with pemetrexed and cisplatin in treatment of advanced NSCLC
  publication-title: Clin Respir J
– volume: 32
  start-page: 1022
  issue: 7
  year: 2021
  end-page: 8
  article-title: Effectiveness of thermal ablation and stereotactic radiotherapy based on stage I lung cancer histology
  publication-title: J Vasc Interv Radiol
– volume: 31
  start-page: 5361
  issue: 7
  year: 2021
  end-page: 9
  article-title: Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case‐control study
  publication-title: Eur Radiol
– volume: 10
  start-page: 53
  issue: 1
  year: 2019
  article-title: Cryoablation and immunotherapy: an overview of evidence on its synergy
  publication-title: Insights Imaging
– volume: 15
  start-page: 1629
  issue: 7
  year: 2019
  end-page: 34
  article-title: Camrelizumab combined with microwave ablation improves the objective response rate in advanced non‐small cell lung cancer
  publication-title: J Cancer Res Ther
– volume: 42
  start-page: 693
  issue: 5
  year: 2019
  end-page: 9
  article-title: Local thermal ablation with continuous EGFR tyrosine kinase inhibitors for EGFR‐mutant non‐small cell lung cancers that developed extra‐central nervous system (CNS) oligoprogressive disease
  publication-title: Cardiovasc Intervent Radiol
– volume: 289
  start-page: 862
  issue: 3
  year: 2018
  end-page: 70
  article-title: Survival rates after thermal ablation versus stereotactic radiation therapy for stage I non‐small cell lung cancer: a National Cancer Database Study
  publication-title: Radiology
– volume: 121
  start-page: 3491
  issue: 19
  year: 2015
  end-page: 8
  article-title: Radiofrequency ablation of stage IA non‐small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial
  publication-title: Cancer
– volume: 30
  start-page: 2692
  issue: 5
  year: 2020
  end-page: 702
  article-title: Microwave ablation plus chemotherapy versus chemotherapy in advanced non‐small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial
  publication-title: Eur Radiol
– volume: 37
  start-page: 141
  issue: 2
  year: 2022
  end-page: 6
  article-title: A clinical study on microwave ablation in combination with chemotherapy in treating peripheral IIIB‐IV non‐small cell lung cancer
  publication-title: Cancer Biother Radiopharm
– volume: 32
  start-page: 5616
  year: 2022
  end-page: 22
  article-title: Microwave ablation treatment for medically inoperable stage I non‐small cell lung cancers: long‐term results
  publication-title: Eur Radiol
– volume: 146
  start-page: 197
  issue: 1
  year: 2020
  end-page: 203
  article-title: Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR‐mutant non‐small cell lung cancer without progression after first‐line EGFR‐TKIs treatment
  publication-title: J Cancer Res Clin Oncol
– volume: 26
  start-page: 320
  issue: 2
  year: 2021
  end-page: 7
  article-title: Chemotherapy combined with intermittent microwave ablation in the treatment of oligometastatic non‐small cell lung cancer
  publication-title: J BUON
– volume: 17
  start-page: 1141
  issue: 5
  year: 2021
  end-page: 56
  article-title: Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition)
  publication-title: J Cancer Res Ther
– ident: e_1_2_8_4_1
  doi: 10.1016/j.radonc.2020.10.028
– ident: e_1_2_8_51_1
  doi: 10.21037/tlcr‐20‐1231
– ident: e_1_2_8_42_1
  doi: 10.4103/jcrt.JCRT_850_20
– ident: e_1_2_8_52_1
  doi: 10.21037/tcr‐20‐3020
– ident: e_1_2_8_17_1
  doi: 10.1186/s13244-021-00997-5
– ident: e_1_2_8_33_1
  doi: 10.1007/s00270-018-02153-x
– ident: e_1_2_8_45_1
  doi: 10.1007/s00256-015-2195-4
– ident: e_1_2_8_37_1
  doi: 10.4103/jcrt.JCRT_798_20
– ident: e_1_2_8_11_1
  doi: 10.1111/1759-7714.14212
– ident: e_1_2_8_38_1
  doi: 10.21037/tlcr‐20‐1075
– ident: e_1_2_8_16_1
  doi: 10.21037/jtd‐2019‐cptn‐08
– ident: e_1_2_8_49_1
  doi: 10.1016/j.yexcr.2021.112910
– ident: e_1_2_8_24_1
  doi: 10.1080/02656736.2020.1756467
– ident: e_1_2_8_50_1
  doi: 10.1016/j.ebiom.2019.05.036
– ident: e_1_2_8_27_1
  doi: 10.1016/j.athoracsur.2018.10.049
– ident: e_1_2_8_6_1
  doi: 10.1007/s00330-020-07634-7
– ident: e_1_2_8_34_1
  doi: 10.1007/s00432-019-03043-6
– ident: e_1_2_8_3_1
  doi: 10.1016/j.jtcvs.2021.01.143
– ident: e_1_2_8_19_1
  doi: 10.21037/atm‐21‐6256
– ident: e_1_2_8_40_1
  doi: 10.1016/j.jvir.2020.09.014
– ident: e_1_2_8_44_1
  doi: 10.1016/j.jvir.2021.03.523
– ident: e_1_2_8_21_1
  doi: 10.3390/cancers13040908
– ident: e_1_2_8_43_1
  doi: 10.1007/s00330-020-07382-8
– ident: e_1_2_8_14_1
  doi: 10.1007/s11912-021-01072-4
– ident: e_1_2_8_8_1
  doi: 10.1148/radiol.2018180979.2018180979
– ident: e_1_2_8_32_1
  doi: 10.1089/cbr.2020.3859
– ident: e_1_2_8_13_1
  doi: 10.1007/s00330‐022‐08615‐8
– ident: e_1_2_8_12_1
  doi: 10.1016/j.crad.2017.01.005
– ident: e_1_2_8_35_1
  doi: 10.4103/jcrt.JCRT_990_19
– ident: e_1_2_8_48_1
  doi: 10.1080/00365513.2019.1689428
– ident: e_1_2_8_53_1
  doi: 10.1093/ejcts/ezac071
– ident: e_1_2_8_25_1
  doi: 10.4103/jcrt.jcrt_1485_21
– volume: 26
  start-page: 320
  issue: 2
  year: 2021
  ident: e_1_2_8_31_1
  article-title: Chemotherapy combined with intermittent microwave ablation in the treatment of oligometastatic non‐small cell lung cancer
  publication-title: J BUON
– ident: e_1_2_8_18_1
  doi: 10.1038/s41416-021-01404-y
– ident: e_1_2_8_28_1
  doi: 10.1007/s00330-020-07675-y
– ident: e_1_2_8_9_1
  doi: 10.4103/jcrt.JCRT_1040_19
– ident: e_1_2_8_20_1
  doi: 10.1016/j.jvir.2021.02.025
– ident: e_1_2_8_5_1
  doi: 10.1016/S1470-2045(08)70155-413
– ident: e_1_2_8_22_1
  doi: 10.21037/jtd.2019.12.12
– ident: e_1_2_8_47_1
  doi: 10.1016/j.biochi.2021.03.007
– ident: e_1_2_8_30_1
  doi: 10.1111/crj.13219
– ident: e_1_2_8_23_1
  doi: 10.4103/jcrt.jcrt_531_21
– ident: e_1_2_8_46_1
  doi: 10.1038/s41423-020-00630-3
– ident: e_1_2_8_10_1
  doi: 10.3389/fonc.2020.571684
– ident: e_1_2_8_7_1
  doi: 10.1002/cncr.29507
– ident: e_1_2_8_15_1
  doi: 10.1111/ajco.13419
– ident: e_1_2_8_26_1
  doi: 10.4103/jcrt.JCRT_377_20
– ident: e_1_2_8_36_1
  doi: 10.4103/jcrt.JCRT_1399_20
– ident: e_1_2_8_2_1
  doi: 10.1002/cncr.31196
– ident: e_1_2_8_54_1
  doi: 10.1016/j.athoracsur.2021.04.061
– ident: e_1_2_8_39_1
  doi: 10.1159/000468982
– ident: e_1_2_8_41_1
  doi: 10.1186/s13244-019-0727-5
– ident: e_1_2_8_29_1
  doi: 10.1007/s00330-019-06613-x
SSID ssj0000389025
Score 2.2664177
Snippet The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant tumors....
Abstract The precise local minimally invasive or noninvasive treatment represents the important orientation for advancing the treatment of pulmonary malignant...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 110
SubjectTerms Ablation
Biomarkers
Cancer therapies
Catheter Ablation - methods
Chemotherapy
Clinical trials
early‐stage
Homogenization
Humans
image‐guided thermal ablation
Insight
issues and prospects
Lung - pathology
Lung cancer
Lung Neoplasms - pathology
Medical prognosis
Medical screening
Metastasis
non‐small cell lung cancer
Patients
pulmonary metastases
Surgery
Surgery, Computer-Assisted
Treatment Outcome
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4p-lBRmJA5eA105s51gqqgqpnFqpt8j22BCpm0Xd3TuPwDP2SZhxvNGuAPXCbeWfxDszHs_EM98w9s74YLXwoUL_R1S1hqayTraV89qIaMEpTcnJ51_12WX95aq52in1RTFhIzzwSLiPyTcOQgQrvaEyud5Ij3KTwKBWhZRxPkUrdpyprINVvj_L2ZBNiyak0AXXh8J4Stu8Rj1harl3JGXk_r-Zm39GTe5as_k4On3EHhY7kh-P63_M7sXhCbt_Xm7Kn7JhLKvH3QAcX5ITKld8mXi_QA1y-_PXt00PETjZfwt8kPNjUBzvB2rjUwA6zfkxQlLkhy3i2lEWUh_4NSoKvt4sljerZ-zy9PPFyVlVaitUAQ08WfkYCawvBWcpWRZAJBtUbQUIcF41ADIqm9DZM6IN4GwQbTKtCEq4FHxUz9nBsBziS8YTzHHb2xoAnbMw187ZpIPxKUicG8WMfdiStwsFeJzqX1x3WweE-NERP7rMjxl7P00of_DfQz8Rv6ZhBJadG1CEuiJC3V0iNGNHW253ZQevOkk3lsK2Gt_xdurGvUcXKm6Iyw2NaZTE06LFMS9G4ZhWojQSs6Yesyc2e0vd7xn67xnfuyWAorpGumUBu4sG3cXJcf7x6n8Q45A9kGjHjV-ZjtjB-mYTX6PdtfZv8hb7DQrsKLE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagSIgL4t2FgozEgUvA6yS2c0KloqqQyqmV9hbZHrus1E3KPu79Cf2N_BJmHG9gxesW-ZXE4xl_tsffMPZGO2-UcL7A9Y8oKgV1YaxsCuuUFsGALRVdTj79ok7Oq8-zepY33FbZrXJrE5Ohht7THvl7SSdIwjRKfrj6VlDUKDpdzSE0brM7U0QiFLpBz_S4x0LkcSLFXcVJskEgKVRm9yFnnpw2rdBa6EruTEyJv_9PoPN338lfMW2alI4fsPsZTfLDQfwP2a3QPWJ3T_N5-WPWDcH1uO2A40vStcoV7yOfL9COfL--udjMIQAnFLjAhqwbXOP4vKM0PrqhU52rgZgiNbYIa0t3keaeX6K54OvNol-unrDz409nRydFjrBQeIR5snAhEGVf9NbQlVkAEY0vKyNAgHVlDSBDaSIu-bRoPFjjRRN1I3wpbPQulE_ZXtd3YZ_xCFNUflMB4BLNT5W1JiqvXfQS6wYxYe-23dv6TD9OUTAu2-0yhOTRkjzaJI8JeztWyD_496IfSV5jMaLMTgn98qLNGthGV1uUGhjpNMVbdlo6NEARsB0DsZywg62026zHq_bnqJuw12M2aiAdq9gu9BsqU5cS54wGyzwbBsf4JaXCzqwoR-8Mm51P3c3p5l8Ty3dDNEVVhf2WBtj_-qA9OzpMD8___R8v2D2JOG3YRTpge-vlJrxEXLV2r5Ly_ABViR9D
  priority: 102
  providerName: ProQuest
Title Issues and prospects of image‐guided thermal ablation in the treatment of primary and metastatic lung tumors
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14742
https://www.ncbi.nlm.nih.gov/pubmed/36480492
https://www.proquest.com/docview/2760008962
https://www.proquest.com/docview/2753291192
https://pubmed.ncbi.nlm.nih.gov/PMC9807444
https://doaj.org/article/fb5adced82b74735b72b531fd7718df3
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtAqWX0ne3TRcVeujFRSvZknxMQkIoJISSQG5Gz9SQtcs-7v0J-Y35JZ2RtSbbB6UXY6yRbGs00ow08w0hH5V1WjLrCrB_WFFKXxXa8LowVioWtDdCYnDy6Zk8uSy_XFUbb0KMhRnwIcYNN5SMNF-jgBu7vCfksO7VoBvOShB2sO8ekl1Q7QUOcl6ej9ssiB_HUurVTM9kBvhBf55f2thamxKE_5_0zt_dJ--rtWldOn5KnmSFku4PI-AZeRC65-TRaT4yf0G6Ib8eNZ2n8JIUWbmkfaTtHKaSux-31-vWB09REZxDQ8YO3nG07fAZHT3Rsc73AZsiNTYPK4PhSK2jNzBj0NV63i-WL8nl8dHF4UmRkywUDjQ9XtgQELUvOqMxatZ7FrUTpWaeeWNF5T0PQkew-hSrnTfasTqqmjnBTHQ2iFdkp-u78IbQ6Gcg_7r0Hqw0N5PG6CidstFxqBvYhHzedG_jMgI5JsK4aTaWCPKjQX40iR8T8mmskH_w76QHyK-RDFGz04N-cd1kIWyirQxwzWtuFaZctopbmIOih3a0j2JC9jbcbrIoLxuOR5dM1xLe8WEsBiHEkxXThX6NNJXgsGzUQPN6GBzjlwgJnVliidoaNluful3Std8S0HeNSEVlCf2WBti_-qC5ONxPN2__t8I78piD8jZsLe2RndViHd6DsrWy0yROcFVXakp2D47Ozr9O08bFTx6nJDQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDcpBRYJJC6Gzdqx14cKtaVVSpsIoVTqzeyzRGrsNg8hbvwEfhE_hl_CzHptiHideov2FXtm_O3M7jwIeZYpLVKmdAT2D4uS1PQjIXkeSZVmzAoj4xSDk4ejdHCcvD3pn6yRb00sDLpVNpjogdpUGs_IX3G8QWIiT_nr84sIq0bh7WpTQkOG0gpmy6cYC4Edh_bzJzDh5lsHb4Dfzznf3xvvDqJQZSDSoOrwSFmLaeuclgLDRo1hTug4EcwwI1XcN4bbWDgwezKWayOFZrnLcqZjJp1WNoZ1r5D1BA9QOmR9Z2_07n17yoPp65iv_ArbdA6qLEtDfiF0JwptvQTwKkv4ytboKwj8Se393XvzV63ab4v7N8mNoM_S7VoAb5E1W94mV4fhxv4OKevyflSWhsKf-MDOOa0cnUwByb5_-Xq6nBhrKOqhU1hIqto5j05KbKOtIzzOOa9TY_jFpnYhMRpqoukZABZdLKfVbH6XHF8K9e-RTlmV9gGhzvQAfkRiDBiJupdKKVyqM-U0h7mWdcnLhryFDgnQsQ7HWdEYQsiPAvlReH50yYt2QnjBvw_dQX61wzBpt2-oZqdFwIDCqb4ErhnBVYYVn1XGFUCgM7COMC7uks2G20VAknnxU-675GnbDRiAFzuytNUSx_RjDrtWDmPu18LRPkmcAjET7MlWxGblUVd7yslHn2c8x0RJSQJ08wL2PxoU491t_2Pj3-_xhFwbjIdHxdHB6PAhuc5Ba6zPtDZJZzFb2keg5S3U4_ApUfLhsr_eH48oY9E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKK1VcEDtDCxgJJC6hHmdzDhXqNmopHVWolXoLXstInaSdRYgbP4Hfxc_gl_Ce4wRGbKfeIm9J3rM_v2e_hZAXudIiY0pHoP-wKMlMGgnJi0iqLGdWGBln6Jx8NMz2T5O3Z-nZEvnW-sKgWWWLiR6oTa3xjHyD4w0SE0XGN1wwizjeHby5vIowgxTetLbpNGRIs2A2fbix4ORxaD9_AnVuunmwC7x_yflg72RnPwoZByINYg-PlLUYws5pKdCF1BjmhI4TwQwzUsWpMdzGwoEKlLNCGyk0K1xeMB0z6bSyMYx7g6zksOuDIriyvTc8ft-d-GAoO-azwMKWXYBYy7IQawhNi0JZPwHsyhO-sE36bAJ_EoF_t-T8VcL2W-TgNrkVZFu61UzGO2TJVnfJ6lG4vb9HqibVH5WVofAS7-Q5pbWjozGg2vcvX8_nI2MNRZl0DANJ1Rjq0VGFZbQzisc-l02YDD_Y2M4kekaNNL0A8KKz-bieTO-T02uh_gOyXNWVfUSoM32AIpEYAwqj7mdSCpfpXDnNoa9lPfK6JW-pQzB0zMlxUbZKEfKjRH6Unh898qrrEH7w7023kV9dMwzg7QvqyXkZ8KB0KpXANSO4yjH7s8q5Ajh0BsYRxsU9st5yuwyoMi1_roEeed5VAx7gJY-sbD3HNmnMYQcroM3DZnJ0XxJnQMwEa_KFabPwqYs11eijjzleYNCkJAG6-Qn2PxqUJztb_uHxv__jGVmFVVy-OxgerpGbHATI5nhrnSzPJnP7BAS-mXoaVhIlH6578f4AcuFoFQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Issues+and+prospects+of+image%E2%80%90guided+thermal+ablation+in+the+treatment+of+primary+and+metastatic+lung+tumors&rft.jtitle=Thoracic+cancer&rft.au=Wang%2C+Meixiang&rft.au=Wei%2C+Zhigang&rft.au=Ye%2C+Xin&rft.date=2023-01-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1759-7706&rft.eissn=1759-7714&rft.volume=14&rft.issue=1&rft.spage=110&rft.epage=115&rft_id=info:doi/10.1111%2F1759-7714.14742&rft_id=info%3Apmid%2F36480492&rft.externalDocID=PMC9807444
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-7706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-7706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-7706&client=summon